Abstract: The purpose of this study was to evaluate the prognostic value of tumor-infiltrating lymphocytes (TILs) in melanoma and to determine whether a simpler numerical scoring system would be more effective. In total, 655 patients presenting to a UK teaching hospital with primary invasive melanoma were analyzed. TILs were rescored using the standard Clark's method and univariable and multivariable analyses of the effect of TILs on overall survival (OS), disease-specific survival (DSS), and metastasis-free survival (MFS) was assessed using Cox regression. In total, 30 (5%) melanomas showed absent, 464 (71%) nonbrisk, and 161 (24%) brisk TILs. There was a statistically significant relationship between TILs and Breslow thickness, age, melanoma type, mitotic rate, and histologic regression. TIL grade was a significant predictor of MFS in multivariable analysis (hazard ratio [HR], 0.44; 95% confidence interval [CI], 0.25-0.77) but was not significant for OS or DSS. By contrast, when a simple numerical TIL percentage score was used this was a strong predictor of OS (HR, 0.55; 95% CI, 0.38-0.78), DSS (HR, 0.25; 95% CI, 0.14-0.44), and MFS (HR, 0.32; 95% CI, 0.21-0.51) in multivariable analysis. The percentage TIL score was also significant when adjusted for the prognostic gold standard, American Joint Committee on Cancer stage: OS (HR, 0.66; 95% CI, DSS (HR, 0.33; 95% CI, and MFS (HR, 0.41; 95% CI,). The TIL percentage score was subsequently validated in new cases. In summary, this study strongly confirms that higher amounts of TILs are associated with better prognosis and in addition demonstrates the value of a simplified numerical TIL scoring system.
M alignant melanoma is a type of skin cancer derived from melanocytes with outcome dependent of clinical stage at diagnosis such that the 93% of patients with early local disease (stage IA) are alive at 10 years, contrasting with only 39% with advanced local disease (stage IIC). 1 The American Joint Committee on Cancer (AJCC) version 7 2 is globally accepted for clinical staging. Nevertheless, stage does not correlate perfectly with outcome so it remains important to identify other factors that might refine its prognostic value.
One histologic prognostic feature of potential value but not currently part of staging is the number of tumorinfiltrating lymphocytes (TILs). In recent years, the emergence of immune checkpoint inhibitors has fueled interest in TILs because these cells are the biological engine underpinning this therapy. The term, "tumor-infiltrating lymphocytes," was first coined by Clark et al, 3 who devised a grading system that has been widely adopted. This recognizes TILs as lymphocytes that directly interact with melanoma cells and is classified as absent, nonbrisk or brisk. The latter 2 can be further regarded as diffuse or peritumoral. Subsequent work has shown that TILs are associated with better prognosis. 4, 5 From a mechanistic perspective, adoptive cell transfer of TILs was associated with tumor regression. 6 In the context of immune therapies, recent work has sought to gather a more nuanced understanding of TIL subpopulations and their functional state 7 and how this relates to the cancerimmunity cycle. 8 So far, we know that increased TILs are a good prognostic feature and that the current Clark grading system remains relevant even in the face of analysis of TIL subclasses and gene expression. 7 However, the standard grading system has potential to be improved. The purpose of the current study was to assess Clark's grading system by completely rescoring TILs in a cohort of 655 cases with relevant endpoints: overall survival (OS), disease-specific, and metastasis-free survival (MFS). We then proceeded to assess a simple numerical scoring system based on the estimated percentage of tumor cells affected by TILs that was then validated in 101 new cases.
METHODS

Study Population
Patients were selected from the archives of the University Hospitals of Leicester Cellular Pathology department. Invasive melanoma cases from January 1, 2004 to December 31, 2009 were retrieved and assessed for inclusion and exclusion criteria. For eligibility, patients had to be resident in Leicestershire and have an unambiguous cutaneous invasive primary melanoma. Patients with multiple skin melanoma were excluded. Patients not resident in Leicestershire were excluded because they had thicker melanomas referred for specialist plastic surgery care and were a biased subset. Moreover, these patients were managed at their local hospital so follow-up data were patchy and incomplete. Patients were screened for eligibility sequentially creating a retrospective incident cohort. In situ, noncutaneous, ambiguous, nonprimary, and non-Leicestershire cases were filtered out, leaving a total of 683 eligible cases. Of these, 10 were excluded because the patient had multiple primary melanomas, 17 because slides were not filed (which was required for TIL scoring), and 1 because the sections were too faded to score. The remaining 655 cases were designated dataset 1. For validation a new set of cases was selected using the same criteria as dataset 1, except that cases had to be >1 mm in Breslow thickness. This extra criterion was added to maximize statistical power from fewer cases, as the power in survival analysis depends on the number of events and the vast majority of these occur in melanomas that are >1 mm thick. Selection commenced from January 1, 2010 and continued until 105 cases were found, this number being chosen to ensure we had approximately 100 after any exclusions. From these, 2 cases were excluded because they were small biopsies with no record of full excision in Leicester, 1 case was not in file, and 1 turned out to be a local recurrence rather than the primary tumor, leaving a total of 101 cases with 42 deaths, 20 melanoma-specific deaths, and 29 developing metastases. This was designated dataset 2.
TIL Scoring
TILs were rescored. Adherence to the scoring system described by Clark was strictly followed 4, 5 with guidance also from the Royal College of Pathologists dataset for reporting of melanoma. 9 The TIL percentage score was measured by estimating the percentage of tumor cells that were disrupted by a lymphocytic infiltrate. As with standard TIL grading, there had to be evidence of disruption of the tumor and/or melanocytic apoptosis. The percentage was estimated from 0% to 100%, to the nearest 10% (but 5% and 95% were allowed at extremes). This method, by design, at once accounts for TIL intensity and extent such that a light, focal intratumoral or peritumoral scattering of TILs would score only 5%, but the TIL percentage score would necessarily increase as the TIL intensity and extent increased. In cases with purely peritumoral TILs, the score would also depend on tumor nodule size, with the proportion cells disrupted decreasing for larger nodules. The primary rater (K.F.) was trained to grade TILs and then 20 randomly selected cases were checked for agreement with a dermatopathologist (G.S.), with a k score of 0.92 for Clark scoring and an intraclass correlation coefficient 0.91 for percentage scoring. This indicates excellent agreement. During subsequent scoring, problematic cases were discussed with dermatopathologists (G.S./M.B.). Examples of TIL percentage scores are shown in Figure 1 
Statistical Analyses
Statistical analyses were all performed in R version 3.2.0. 10 For bivariable analysis of TILs and other covariables, w 2 and analysis of variance tests were used, using the R Gmisc package. 11 Survival analyses were performed using the R survival package 12 and Kaplan Meier plots generated using the R survminer package. 13 Time to event analysis was performed with 3 outcomes, OS, disease-specific survival (DSS), and MFS. The date of diagnosis was the date of primary sample accession in the pathology database. For OS, failure was death from any cause while for DSS death from melanoma was considered as failure and death from another cause was regarded as censoring. For MFS, the event was the time of first metastasis (either locoregional or distant). Survival was analyzed by the Kaplan Meier method and log rank tests were used to compare survival curves. Univariable and multivariable hazard ratios (HRs) were determined using Cox proportional hazards method. The proportionality assumption was checked by examining plots of scaled Schoenfeld residuals against transformed time and with a goodness of fit test. Proportionality was not violated. Crude and adjusted HR tables for Cox regression were generated using the R html Table package 14 and edited in MS word.
(5%), nonbrisk in 464 (71%), and brisk in 161 (24%). The baseline features for all cases and those within each TIL category are shown in Table 1 .
The cases in this study were relatively thin melanomas. The median Breslow thickness of 0.9 mm reflects the incident melanomas at the study location, which in turn reflects incident melanomas in the United Kingdom in general. 16 Microscopic satellites were not frequently identified (9% of cases) and regression was present in 21% of cases. TILs had a statistically significant relationship with Breslow thickness, with fewer TILs in thick melanomas. There was an association with age, with brisk TILs being more frequent in younger individuals. Brisk TILs were much less common in acral melanomas. TILs had a significant relationship to mitotic rate, with mitoses being more frequent in the nonbrisk and brisk groups compared with absent. TILs were more commonly found when histologic regression was also present.
The relationship between TILs and survival was first assessed using Kaplan Meier estimates of the survivor function for 3 outcome events, OS, DSS, and MFS. The median follow-up was 78 months. With careful rescoring using strict adherence to standard criteria for TIL grading, there were only 30 cases where TILs were absent. Among these, there were only 6 deaths, 3 disease-specific deaths, and 5 metastases. In view of the small size of this group and the low number of events, the absent and nonbrisk TIL groups were combined. The Kaplan Meier survival plots are shown in Figures 2A-C alongside the number at risk per stratum. The 5-year OS for absent/nonbrisk and brisk TILs was 80% and 88%, respectively, and corresponding values for DSS were 89% and 95%, and MFS were 81% and 92%, respectively. The survival curves for each of these outcomes were significantly different.
A Cox proportional hazards model was created to assess the univariable and multivariable statistical effect of TILs on OS, DSS, and MFS. Once again, TILs were analyzed as 2 groups, absent/nonbrisk and brisk, with the former as the reference category. The model included standard clinicopathologic covariables associated with outcome: Breslow thickness, ulcer, mitotic rate, microscopic satellites, histologic regression, age, sex, and site. The results are shown in Table 2 , where both crude and adjusted HRs are shown. Adjusted HRs for TILs were only significant for the surrogate endpoint of MFS and not for the most objective endpoint, OS, nor for DSS. The only variables that were significant for all outcome events in multivariable analysis were sex, mitotic rate, and ulceration. An unabridged version of Table 2 is shown in Supplementary Table A2 (Supplemental Digital Content 1, http://links.lww.com/PAS/A503).
The recognized system for TIL grading attempts to incorporate 2 features, pattern (peritumoral and diffuse) and intensity (absent, nonbrisk, and brisk). This could have potential issues, for example brisk peritumoral TILs might only interact with a small percentage of melanoma cells at the edge of a tumor island while a brisk diffuse TIL infiltrate in a tumor island of the same size will interact with a high percentage of melanoma cells. This difference is not recognized within the brisk category. We therefore devised a simple TIL percentage score, where the proportion of melanoma affected by TILs was estimated from H&E-stained sections and scored from 0% to 100%. The mean percentage score was 22%, with a median of 20% and a range of 0% to 90%. To perform Kaplan Meier analysis, the TIL percentage score was broken into 3 categories based on tertiles and survival curves were compared. The tertiles corresponded to 0% to 5%, 10% to 20%, and Z30%. The Kaplan Meier survival plots are shown in Figures 2D-F alongside the number at risk per stratum. The 5-year OS for upper, middle, and lower tertiles was 91%, 88%, and 66%, respectively. Corresponding values for DSS were 98%, 97%, and 77% and for MFS were 95%, 91%, and 62%. These survival curves differed significantly for all 3 outcomes. The Kaplan Meier estimates of the survivor function showed that the curves for the 2 higher tertiles substantially overlapped. It therefore seemed sensible to combine these 2 groups for subsequent analysis using Cox proportional hazards regression, thus creating a group of 0% to 5% and 10% or more. The proportional hazards regression analysis is shown in Table 3 . The crude HRs for all variables in the model except TIL percentage score were shown in Table 2 , so are not repeated in This suggests that when as few as 10% of the melanoma cells are involved by TILs the prognosis improves independently of AJCC stage. The 10% cutpoint for creating the TIL percentage score risk strata emerged from the data as a discovery rather than being specified a priori, therefore we sought to validate the cutpoint in dataset 2, a new set of 101 melanomas. These cases were all >1 mm. The results of multivariable analysis are shown in Table 5 alongside the same analysis in a 312 case subset of dataset 1, comprising only cases >1 mm thick. The analysis was limited to this subset to make datasets 1 and 2 comparable. The cutpoint was significant for OS, DSS, and MFS in both the 312 case subset of dataset 1 and in the 101 cases in dataset 2, indicating that the risk strata based on a cutpoint of 10% can be generalized to new cases.
DISCUSSION
This is a large single center retrospective cohort study assessing the prognostic significance of TILs in melanoma prognosis. The strong aspects of this study are the large numbers of patients (655), the fact that these represent a true unbiased incident cohort, that the TIL grade was rescored for all tissue samples to avoid interobserver bias, that we assessed 3 important endpoints (OS, DSS, and MFS), that we included important covariables in regression analysis, and that we validated the cutpoint for stratifying TIL percentage score with new cases. Most crucially we show that the prognostic value of TILs assessment can be enhanced by simply estimating the percentage of tumor cells involved by TILs and that this remains significant in multivariable analysis even when standard TIL grading using Clark's system does not. These findings are very timely, given the known role of the immune system in determining cancer behavior and the emerging role of immune checkpoint inhibition in melanoma care.
While this study has several strong points, there were some issues. It should be recognized that this is a single center study so there is a need to demonstrate that the findings can be generalized. In contrast, the general demographic features of the patients were consistent with those seen in the United Kingdom and western countries. There is also the concern that the TILs in dataset 1 were scored by a single rater, so there is a risk that the rater rather than the grading system is being tested. However, the rater was intensively trained in TIL scoring, discussed difficult cases with dermatopathologists (G.S. and M.B.) and had a low threshold for deciding if discussion was required. In addition the agreement score for the rater and a dermatopathologist (G.S.) for TIL grade was very high and a different scorer was used for the validation case scoring. A final issue was that sentinel node biopsy was not a part of standard care during the recruitment period in the study center, so there was no possibility to use sentinel node status as an outcome measure. This was mitigated by the fact that we were able to assess 3 other outcome events, OS, DSS, and MFS.
It has been nearly 40 years since TILs were first recognized as a prognostic factor for melanoma 17 and since then evidence has accumulated steadily. The present study strongly supports the idea that increasing amounts of TILs are associated with better outcome. Internationally, TILs scoring has been standardized using Clark's system of absent, nonbrisk and brisk, but there have been attempts to improve this. The most notable example, because of the large sample size and analysis of the association between TIL score and sentinel node status, was the 4 tier system used by Azimi et al. 18 This system attempted to amalgamate the pattern of infiltration (focal, multifocal, diffuse) with the intensity (absent, mild, moderate, marked) which could be cross-tabulated into a grade (0 to 4). Using this system, TIL grade was an independent prognostic factor for DSS, recurrence-free survival, and for predicting sentinel node status. A big advantage of this novel grading system was that it addressed a problem with Clark grading, in particular involvement of the entire base of tumor by peritumoral TILs is labelled brisk, yet only a small proportion of tumor cells might be interacting with TILs because in cases with large tumor nodules most melanoma cells reside in the central part of a tumor mass. Evidence suggests that this is not merely a theoretical problem, because in the grading system described by Azimi and colleagues brisk peritumoral TILs ranged from a low grade of 1 to high grade of 3 (see Table A2 from the article Azimi et al 18 ) . A potential problem with Azimi's system is that there is a subjective element in deciding whether the TIL intensity is mild, moderate, or marked. The system we used also has a subjective element, being semiquantitative, but is very simple and requires no cross tabulation of pattern and intensity. One merely estimates the proportion of dermal melanoma disrupted by TILs and assigns a percentage to the nearest 10%. This system had a very strong interobserver agreement. Importantly, this percentage TIL score was strongly significant in multivariable analysis for OS, DSS, and MFS with 8 other covariables, which was not the case for TIL grading by the Clark system. Furthermore, the novel scoring system showed independent prognostic value in a prognostic model that included the gold standard for prognosis, AJCC stage. In AJCC staging, the Breslow depth, ulceration, and microscopic satellites are all recognized histologic features. 1 More recently, evidence about mitotic rate [19] [20] [21] has led to its inclusion in AJCC staging too. The evidence from the present study and previous data strongly support the inclusion of TILs grade in pathology reports. Routine inclusion is important so that further studies of TILs in melanoma prognosis can be enabled. Indeed, inclusion of TIL grading is required in pathology reports in the United Kingdom by the Royal College of Pathologists 9 and inclusion is recommended in UK guidelines for melanoma management. 22 TIL grade is also supported as a data item by the American Academy of Dermatology 23 and TILs are an essential feature of the Armed Forces Institute of Pathology 8-year survival prognostic model. 24 More recently, TILs have become important because they may have a role in determining the response to immune therapy. In this regard, TIL response in metastases is likely to be more important than primary melanoma but nevertheless a clearer understanding of TILs in primary melanoma is likely to add to our overall understanding of this phenomenon. The present study has focused on the simple histologic scoring of TILs, but dissecting the fine detail of TIL subpopulations and their complex interactions with melanoma cells will become increasingly important as a predictive biomarker for immune therapy and is an area of intense research.
In summary, this study strongly supports earlier data showing that increased amounts of TILs are associated with better prognosis. The study evaluated important 
